Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome subunit alpha type-7 (PSMA7) is a core component of the 20S proteasome complex, which is essential for the ATP/ubiquitin-dependent degradation of most intracellular proteins in eukaryotic cells. It plays a central role in protein quality control, antigen processing, and regulation of cellular pathways, including those involving HIF-1α and NOD1. PSMA7's role in tumor growth and its interactions with viral proteins suggest its involvement in disease mechanisms. Overexpression has been linked to colorectal cancer progression and liver metastasis.
Inhibition of proteasome activity, modulation of HIF-1α levels, modulation of NOD1 signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome subunit alpha type-7 (PSMA7).